info icon

This is a non-core endpoint: only basic statistics are computed.

Anaemia due to enzyme disorders

D3_ANAEMIAENZYME

congenital nonspherocytic hemolytic anemia: Any one of a group of congenital hemolytic anemias in which there is no abnormal hemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. In some cases, pyruvate kinase deficiency has been demonstrated; in other cases, glucose-6-phosphate dehydrogenase deficiency has been demonstrated.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D55
Hospital discharge: ICD-9 282[2-3]
Hospital discharge: ICD-8 282[2-3]
Cause of death: ICD-10 D55
Cause of death: ICD-9 282[2-3]
Cause of death: ICD-8 282[2-3]

2 out of 7 registries used, show all original rules.

34

diagram downward connector

Check minimum number of events None

34

diagram downward connector

Include endpoints None

34

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

32

diagram downward connector
D3_ANAEMIAENZYME

Control definitions

Control exclude D3_HAEMOLYTICANAEMIA

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 D55-D59
Name in latin Anaemiae ex perturbationibus enzymaticis

Summary Statistics

Key figures

All Female Male
Number of individuals 32 19 13
Unadjusted prevalence (%) 0.01 0.01 0.01
Mean age at first event (years) 46.61 41.81 53.61

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: D3_ANAEMIAENZYME – Anaemia due to enzyme disorders
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Anaemia due to enzyme disorders

Endpoint not on priority list, no data to show.